Stocks were looking at a strong open on Monday with the Dow, S&P 500 and NASDAQ all looking at gains of 0.5% or more. Stocks are at all-time highs, the election is over, a new regime and new policies are coming, and now investors need to be planning how to position for 2025 and beyond. This is where Wall Street research can come into play with Wall Street’s top market pundits having some insights to share.
Oggonomics searches the daily flow of analyst research reports covering the upgrades, downgrades and initiations from Wall Street looking for new ideas. These analyst reports generally try to look out a year out into the future and often have new ideas that might have otherwise been overlooked or missed.
Some analyst calls are just reactionary to earnings and other news, but some analyst calls are preemptive and can move stocks. Short-term traders get a glimpse of immediate price reactions to news and to the analyst calls. Long-term investors get a picture of new buy, sell and hold ratings with targets looking a year out.
Oggonomics always reminds investors and its readers that no single analyst report should ever be the sole basis to buy or sell a stock. That decision to buy or sell, or hold or short sell, is up to each investor and the decision should be made with a financial advisor. And there are of course no assurances that any of the price predictions and the scenarios that back the calls up will actually come to fruition.
These are the top analyst upgrades, downgrades and initiations from Monday, November 25, 2024.
Arm Holdings plc (NASDAQ: ARM) was initiated as Buy with a $160 price target (vs. $135.99 close) at UBS.
Chewy, Inc. (NYSE: CHWY) was reiterated as Outperform and its price target was raised to $40 from $35 (vs. $34.89 close) at Baird.
Constellation Brands, Inc. (NYSE: STZ) was initiated at Neutral by Exane BNP Paribas.
CrowdStrike Holdings, Inc. (NASDAQ: CRWD) was reiterated as Buy with price target raised to $385 from $325 (vs. $372.26 close) at Rosenblatt. CrowdStrike has seen about 10 analysts hiking their targets and expectations ahead of earnings and now the shares are “back to even” from the software upgrade SNAFU.
Domino’s Pizza, Inc. (NYSE: DPZ) was reiterated at Buy with price target raised to $515 from $475 at TD Cowen.
Eagle Materials Inc. (NYSE: EXP) was cut to Hold from Buy at Loop Capital.
Elastic N.V. (NYSE: ESTC) was raised to Outperform from Neutral with $135 price target (vs. $108.03 close) at Wedbush.
Expensify, Inc. (NASDAQ: EXFY) was downgraded to Market Perform from Market Outperform at JMP Securities.
Five Below, Inc. (NASDAQ: FIVE) was downgraded to Market Perform from Outperform at Telsey Advisory Group.
HCA Healthcare, Inc. (NYSE: HCA) was cut to Underweight from Equal-Weight with price target cut to $320 from $400 (vs. $324.93 prior close) at Wells Fargo.
Immunic, Inc. (NASDAQ: IMUX) was initiated with a Buy rating and was assigned a $10 price target at HC Wainwright. Immunic closed at $1.10 ahead of the call and has a mere $100 million market cap.
M&T Bank Corporation (NYSE: MTB) was downgraded to Neutral from Buy at Citigroup.
MARA Holdings, Inc. (NASDAQ: MARA), the former Marathon Digital, was initiated with an Equal-Weight rating at Barclays.
MicroStrategy, Inc. (NASDAQ: MSTR) was reiterated as Buy and its price target was raised to $510 from $300 (vs. $421.88 close) at Canaccord Genuity. Barclays also reiterated its Overweight rating and raised its target to $515 from $275. Benchmark reiterated its Buy rating and raised its target to $650 from $450.
ALSO READ: 10 DRIVERS TAKING BITCOIN TO $100K
Molson Coors Beverage Company (NYSE: TAP) was initiated at Neutral at Exane BNP Paribas.
Monday.com (NASDAQ: MNDY) was named the Bull of the Day at Zacks, noting that the business software company ripping off impressive earnings and revenue growth.
NIO Inc. (NYSE: NIO) was downgraded to Sell from Neutral and its price target was cut to $3.90 from $4.80 (vs. $4.84 close) at Goldman Sachs.
Palantir Technologies Inc. (NYSE: PLTR) was maintained with a Buy and its price objective raised to $75 from $55 at B of A Securities; Palantir was also reiterated with an Outperform rating and its price target was raised to $75 from $57 at Wedbush. Palantir closed at $64.35 ahead of the call.
Perspective Therapeutics, Inc. (NASDAQ: CATX) was downgraded to Neutral from Buy and its price objective was slashed down to $6 from $24 at BofA Securities. Perspective Therapeutics closed at $3.47 ahead of the call.
Polaris Inc. (NYSE: PII) was named the Bear of the Day at Zacks, noting that Polaris fell short of its Q3 earnings estimate in late October and its EPS outlook has tanked over the last year.
The Procter & Gamble Company (NYSE: PG) was raised to Buy from Neutral and its price target was raised to $209 from $160 (vs. $176.28 close) at DA Davidson.
Red Rock Resorts, Inc. (NASDAQ: RRR) was downgraded to Neutral from Outperform with price target cut to $44 from $57 (vs. $50.85 prior close) at Mizuho.
Salesforce, Inc. (NYSE: CRM) was reiterated as Outperform and its price target was raised to $375 from $325 (vs. $342.02 close) at Wedbush.
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) was started with a Sell rating with a $80 target (vs. $114.23 prior close) at HC Wainwright & Co.
Shoals Technologies Group, Inc. (NASDAQ: SHLS) was initiated at Buy with a $6 price objective (versus $4.83 prior close) at BofA Securities.
Snowflake Inc. (NYSE: SNOW) was raised to Outperform from Neutral with a $190 price target (versus $167.44 prior close) at Wedbush.
U.S. Bancorp (NYSE: USB) was raised to Buy from Neutral and its price target was raised to $65 from $49 (vs. $53.54 prior close) at Citigroup.
W.R. Berkley (NYSE: WRB) was raised to Buy from Neutral with a $69 target price (vs. $62.27 prior close) at Goldman Sachs.
Here are 9 ANALYST STOCK PICKS CALLED TO RISE 100% from the prior week.
